Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks (Q2158358)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks |
scientific article; zbMATH DE number 7562785
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks |
scientific article; zbMATH DE number 7562785 |
Statements
Covid-19 vaccine approvals and stock market returns: the case of Chinese stocks (English)
0 references
26 July 2022
0 references
COVID-19
0 references
vaccine news
0 references
stock market returns
0 references
0.7598446011543274
0 references
0.743239164352417
0 references
0.7141806483268738
0 references
0.6609793901443481
0 references
